Ling Chen Selected Research

Buformin

10/2018	Buformin increases radiosensitivity in cervical cancer cells via cell-cycle arrest and delayed DNA-damage repair.
1/2018	Buformin suppresses proliferation and invasion via AMPK/S6 pathway in cervical cancer and synergizes with paclitaxel.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ling Chen Research Topics

Disease

253	Neoplasms (Cancer) 10/2022 - 01/2002
76	Infections 01/2022 - 01/2002
58	Inflammation (Inflammations) 10/2022 - 04/2008
38	Breast Neoplasms (Breast Cancer) 02/2022 - 04/2002
33	Stomach Neoplasms (Stomach Cancer) 06/2022 - 11/2006
31	Type 2 Diabetes Mellitus (MODY) 10/2022 - 01/2011
31	Neoplasm Metastasis (Metastasis) 02/2022 - 12/2005
28	Carcinoma (Carcinomatosis) 10/2022 - 04/2002
27	Glioma (Gliomas) 01/2022 - 09/2011
25	Parkinson Disease (Parkinson's Disease) 12/2021 - 12/2003
24	Insulin Resistance 11/2021 - 06/2012
23	Fibrosis (Cirrhosis) 01/2022 - 09/2011
23	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 02/2006
23	Obesity 08/2021 - 02/2009
21	Lung Neoplasms (Lung Cancer) 06/2022 - 03/2008
21	Ovarian Neoplasms (Ovarian Cancer) 04/2022 - 10/2003
21	Lymphatic Metastasis 01/2022 - 01/2006
20	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2022 - 03/2010
18	Carcinogenesis 04/2022 - 03/2007
18	Hypertension (High Blood Pressure) 01/2022 - 11/2005
17	Hepatocellular Carcinoma (Hepatoma) 03/2022 - 12/2010
16	Body Weight (Weight, Body) 08/2022 - 02/2009
15	Hypoxia (Hypoxemia) 01/2022 - 02/2010
15	Uterine Cervical Neoplasms (Cancer of the Cervix) 09/2021 - 11/2007
14	COVID-19 01/2022 - 01/2020
14	Endometrial Neoplasms (Endometrial Cancer) 01/2022 - 01/2016
14	Human Influenza (Influenza) 01/2021 - 01/2011
13	Brain Ischemia (Cerebral Ischemia) 09/2022 - 01/2009
13	Virus Diseases (Viral Diseases) 01/2022 - 01/2002
13	Macular Degeneration (Age-Related Maculopathy) 01/2022 - 03/2002
13	Ischemia 01/2022 - 10/2006
13	Stroke (Strokes) 01/2020 - 01/2009
12	Cognitive Dysfunction 05/2021 - 01/2009
11	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2013
11	Heart Failure 01/2022 - 01/2004
11	Pain (Aches) 09/2021 - 08/2009
10	Glioblastoma (Glioblastoma Multiforme) 10/2022 - 01/2012
10	Asthma (Bronchial Asthma) 10/2022 - 01/2014
10	Epilepsy (Aura) 03/2022 - 11/2011
10	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 01/2012
10	Adenocarcinoma 01/2022 - 03/2012
10	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 07/2009
10	Diabetes Mellitus 01/2022 - 02/2011
10	Hemorrhage 01/2021 - 10/2013
9	Myocardial Infarction 01/2022 - 01/2004
9	Uterine Neoplasms (Uterine Cancer) 01/2022 - 05/2014
8	Sepsis (Septicemia) 02/2022 - 01/2012
8	Infarction (Infarctions) 01/2022 - 01/2004
8	Atrophy 01/2022 - 01/2019
8	Seizures (Absence Seizure) 01/2022 - 07/2014
8	Pneumonia (Pneumonitis) 12/2021 - 01/2014
8	Memory Disorders (Memory Loss) 12/2021 - 02/2013
8	Hyperalgesia 09/2021 - 08/2015
8	Lymphoma (Lymphomas) 06/2021 - 05/2005

Drug/Important Bio-Agent (IBA)

95	Proteins (Proteins, Gene)FDA Link 08/2022 - 10/2003
58	Biomarkers (Surrogate Marker)IBA 09/2022 - 05/2009
48	Pharmaceutical PreparationsIBA 01/2022 - 01/2002
48	MicroRNAs (MicroRNA)IBA 01/2022 - 03/2010
43	Messenger RNA (mRNA)IBA 01/2022 - 08/2004
40	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 09/2005
33	CytokinesIBA 08/2022 - 01/2011
33	VaccinesIBA 06/2022 - 01/2002
24	Peptides (Polypeptides)IBA 11/2020 - 02/2006
23	Biological ProductsIBA 01/2022 - 09/2008
20	AntigensIBA 01/2019 - 06/2006
19	LipidsIBA 01/2022 - 12/2009
18	Long Noncoding RNAIBA 01/2022 - 01/2013
18	Insulin (Novolin)FDA Link 01/2021 - 06/2012
17	Indicators and Reagents (Reagents)IBA 01/2022 - 03/2010
15	AntibodiesIBA 03/2022 - 10/2008
15	Retinaldehyde (Retinal)IBA 01/2022 - 03/2002
15	Interleukin-6 (Interleukin 6)IBA 01/2022 - 12/2010
15	RNA (Ribonucleic Acid)IBA 01/2022 - 10/2005
14	EnzymesIBA 02/2022 - 01/2002
13	Therapeutic UsesIBA 12/2021 - 01/2002
12	DNA (Deoxyribonucleic Acid)IBA 03/2020 - 01/2002
11	Small Interfering RNA (siRNA)IBA 04/2022 - 06/2011
11	LigandsIBA 02/2021 - 06/2006
10	Immune Checkpoint InhibitorsIBA 06/2022 - 06/2019
10	CateninsIBA 05/2022 - 01/2015
10	Phosphotransferases (Kinase)IBA 01/2022 - 01/2005
10	Blood Glucose (Blood Sugar)IBA 12/2021 - 05/2013
10	LipopolysaccharidesIBA 05/2021 - 12/2010
9	CollagenIBA 01/2022 - 09/2014
9	Cisplatin (Platino)FDA LinkGeneric 12/2021 - 12/2013
9	Monoclonal AntibodiesIBA 12/2021 - 02/2009
9	Antiviral Agents (Antivirals)IBA 10/2021 - 01/2002
9	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2020 - 02/2007
8	Interleukin-17 (Interleukin 17)IBA 10/2022 - 05/2009
8	AntioxidantsIBA 11/2021 - 09/2005
8	Paclitaxel (Taxol)FDA LinkGeneric 02/2021 - 12/2008
8	Amyloid (Amyloid Fibrils)IBA 01/2021 - 02/2013

Therapy/Procedure

119	Therapeutics 06/2022 - 01/2002
56	Drug Therapy (Chemotherapy) 10/2022 - 04/2002
28	Immunotherapy 10/2022 - 12/2006
21	Hysterectomy 01/2022 - 02/2015
18	Radiotherapy 04/2022 - 12/2008
13	Aftercare (After-Treatment) 01/2022 - 08/2012
9	Transplantation 12/2021 - 05/2011
8	Intravenous Injections 10/2021 - 01/2012